000 01176 a2200349 4500
005 20250517082859.0
264 0 _c20171211
008 201712s 0 0 eng d
022 _a1949-2553
024 7 _a10.18632/oncotarget.7590
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLin, Ziying
245 0 0 _aThe prevalence and clinicopathological features of programmed death-ligand 1 (PD-L1) expression: a pooled analysis of literatures.
_h[electronic resource]
260 _bOncotarget
_cMar 2016
300 _a15033-46 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis
650 0 4 _aB7-H1 Antigen
_xmetabolism
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aHumans
650 0 4 _aLymphatic Metastasis
650 0 4 _aNeoplasm Staging
650 0 4 _aNeoplasms
_xmetabolism
650 0 4 _aPrognosis
700 1 _aXu, Yutong
700 1 _aZhang, Yaxiong
700 1 _aHe, Qihua
700 1 _aZhang, Jianrong
700 1 _aHe, Jianxing
700 1 _aLiang, Wenhua
773 0 _tOncotarget
_gvol. 7
_gno. 12
_gp. 15033-46
856 4 0 _uhttps://doi.org/10.18632/oncotarget.7590
_zAvailable from publisher's website
999 _c25784471
_d25784471